This is an old revision of this page, as edited by PotatoBot (talk | contribs) at 15:35, 30 July 2010 (Stub sorting and placement of stub template(s): musculoskeletal-drug-stub). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 15:35, 30 July 2010 by PotatoBot (talk | contribs) (Stub sorting and placement of stub template(s): musculoskeletal-drug-stub)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C5H15NO7P2 |
| Molar mass | 263.12 g/mol g·mol |
Olpadronic acid (INN; salt form olpadronate) is a bisphosphonate.
| Drugs for treatment of bone diseases (M05) | |
|---|---|
| Bisphosphonates | |
| Bone morphogenetic proteins | |
| Other |
|
 | This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |